INVESTING IN
BREAKTHROUGH
HEALTH INNOVATIONS
Merck Global Health Innovation (GHI) invests in emerging companies that deliver breakthrough health care solutions, and which advance Merck's mission to discover, develop and provide innovative products and services that save and improve lives.

ACCELERATING VALUE

Global Health Innovation (GHI) has a focused, strategic investment approach designed to unlock the full value of health care innovations from around the world.

  • Building Connected Health solutions - In newly emerging healthcare spaces, GHI recognizes that the winners will provide integrated healthcare solutions.
  • Applying a partnering mindset - Our approach creates new value for customers by combining solutions from portfolio companies and partners.
  • Bringing the power of Merck - Access to leading science, supply chain, commercial channel, marketing and regulatory experts around the world.

Forward Looking Statement

This website includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future financial and operating results, the combined company's plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Merck's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.

The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the possibility that all of the expected synergies from the merger of Merck and Schering-Plough will not be realized, or will not be realized within the expected time period; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; Merck's ability to accurately predict future market conditions; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck's 2011 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).